1. Home
  2. SME IPO
  3. Saroja Pharma Industries India Ltd IPO
Saroja Pharma IPO

Saroja Pharma Industries India IPO

  • Status: Closed
  • RHP:
  • ₹ 134,400 / 1600 shares

    Minimum Investment

IPO Details

  • Open Date

    31 Aug 2023

  • Close Date

    05 Sep 2023

  • IPO Price Range

    ₹ 84

  • IPO Size

    ₹ 9.11 Cr

  • Listing Exchange

    NSE SME

  • Listing Date

    13 Sep 2023

With just a few clicks, Invest in IPO's!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Objective Financials SWOT FAQ Contacts

IPO Timeline

Saroja Pharma Industries India IPO Subscription Status

Last Updated: 03 January 2024 8:57 PM by 5Paisa

Saroja Pharma Industries India Limited IPO is all set to open from 31st August to 5th September  2023. The company is in the business of trading, exporting and supplying Specialty Chemicals & API. The IPO includes a fresh issue of  10,84,800 shares worth ₹9.11 cr. The share allotment date is 8th September, and the IPO will be listed on 13th September on the stock exchanges. The price is ₹84 per share and the lot size is 1600 shares.

Swastika Investmart Limited is the book-running lead manager for this IPO, while Kfin Technologies Limited is the registrar. 

Objectives of Saroja Pharma Industries IPO:

Saroja Pharma Industries plans to utilize the raised capital from the IPO to:
●    To fund a manufacturing unit
●    To repay the outstanding unsecured loans
●    To meet the public issue expense
 

Established in 2019, Saroja Pharma Industries was established with the primary goal of providing the best service in chemical trading, with premium pharmaceutical companies in India and abroad to offer cost-effective solutions in human and veterinary medicine. The company specializes in trading Pharma API, Pharma Intermediates, Chemicals, and Solvents, all essential for the production of pharmaceutical and medical products. 

Saroja Pharma has three distinct product categories: i) Chemicals ii) Pharma Intermediaries iii) Veterinary Pharma API. It offers a wide range of products including Liquide Bromine, utilized as an agro-intermediate, as well as Ethyl Acetate, serving as an API solvent. 

The company also exports products to Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore, and more.

Peer Comparison

●    NGL Fine Chem Limited
●    Sequent Scientific Limited

For More Information:
Webstory on Saroja Pharma IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY22 FY21
Revenue 50.19 55.63 36.66
EBITDA 2.87 2.42 1.38
PAT 1.06 1.14 0.73
Particulars (in Rs. Crores) FY23 FY22 FY21
Total Assets 21.34 15.51 8.22
Share Capital 2.93 0.22 0.01
Total Borrowings 16.25 11.48 7.28
Particulars (in Rs. Crores) FY23 FY22 FY21
Net cash generated from / (used in) operating activities 2.19 -3.67 -1.04
Net cash from / (used in) investing activities -4.82 -0.33 -0.05
Net cash flow from / (used in) financing activities 2.73 4.26 1.02
Net increase (decrease) in cash and cash equivalents 0.099 0.26 -0.07


Strengths

1.    The company has a scalable business model. 
2.    Vast product portfolio.
3.    The company’s operation and revenue base are diverse. 
4.    Experienced promoters and management. 
 

Risks

1.    Domestic sales are dependent on only five States in India.
2.    Negative cash flows in the past.
3.    The company can be impacted by forex fluctuations. 
4.    Operates in a highly competitive industry.  

Will You Apply for Saroja Pharma Industries India IPO?

Yes No Maybe

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
footer_form

FAQs

The minimum lot size of Saroja Pharma Industries IPO is 1600 shares and the investment required is ₹1,34,400.

The price band of Saroja Pharma Industries IPO is ₹84 per share. 

Saroja Pharma Industries IPO opens from 31st August to 5th September 2023.
 

The size of Saroja Pharma Industries IPO is ₹9.11 cr. 

The share allotment date of Saroja Pharma Industries IPO is 8th September 2023.

The Saroja Pharma Industries IPO will be listed on 13th September 2023.

Swastika Investmart Limited is the book-running lead manager for Saroja Pharma Industries IPO.

Saroja Pharma Industries plans to utilize the raised capital from the IPO to:

1.    To fund a manufacturing unit
2.    To repay the outstanding unsecured loans
3.    To meet the public issue expense 
 

To apply for Saroja Pharma Industries IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for the Saroja Pharma Industries IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    
●    You will receive a mandate notification to block funds in your UPI app.